/9918578/Banner

/9918578/Banner_2

/9918578/Mid

section

articleId

product

orgType

parrefer

accountID

Consulting

Banking

Accounting

Fintech

Internships

Rankings

Internship Rankings

Intern Resource Center

Explore Internships

Vault Law Home

Practice Area Resource Centers

Regional Resource Centers

Summer Program Resource Center

Vault Law Culture & Inclusion Survey

Vault Law

Guides

Events

Financial Services

Technology

Grad School

Work Relationships

Productivity

Diversity, Equity & Inclusion

Social Impact

Remote Work

Negotiating

Changing Jobs

Workplace Issues

Blog

Resume Samples

Cover Letter Samples

Interview Tips & Questions

A Day in the Life

International

Career Readiness

Explore Professions

Research Industries

Search Companies

Career Advice

Employers

Schools

&lt;p&gt;Following last week’s &lt;a href=&quot;/blog/vaults-law-blog-legal-careers-and-industry-news/which-lawyers-are-lining-up-for-botox/&quot; target=&quot;_blank&quot;&gt;flurry of pharma deal activity&lt;/a&gt;, on Monday &lt;a href=&quot;/company-profiles/pharmaceuticals-and-biotechnology/pfizer-inc/company-overview.aspx&quot; target=&quot;_blank&quot;&gt;Pfizer&lt;/a&gt; announced its intention to acquire British drug maker and serious competitor &lt;a href=&quot;/company-profiles/pharmaceuticals-and-biotechnology/astrazeneca-pharmaceuticals-lp/company-overview.aspx&quot; target=&quot;_blank&quot;&gt;AstraZeneca&lt;/a&gt;. The potential $100 billion dollar acquisition would be one of the largest pharma deals in history, topping Pfizer’s $90 billion purchase of Warner-Lambert in 2000. Among other reasons (such as the tax benefits of doing business outside the U.S.) AstraZeneca’s vast portfolio of cancer drugs makes it an attractive purchase. And who of the illustrious top law firms has the pleasure of advising on this proposed megadeal? &lt;a href=&quot;/company-profiles/law/skadden,-arps,-slate,-meagher-flom-llp-and-affiliates/company-reviews&quot; target=&quot;_blank&quot;&gt;Skadden&lt;/a&gt; is representing Pfizer (a longtime client), drawing on its expertise in the corporate, tax and competition arenas in both the U.S. and London. AstraZeneca has turned to &lt;a href=&quot;/company-profiles/law/davis-polk-wardwell/company-reviews&quot; target=&quot;_blank&quot;&gt;Davis Polk&lt;/a&gt; and &lt;a href=&quot;/company-profiles/law/freshfields-bruckhaus-deringer-llp-(us)/company-reviews&quot; target=&quot;_blank&quot;&gt;Freshfields&lt;/a&gt; to advise it on Pfizer’s proposal. (Both firms have previously worked on deals for the company.) In January AstraZeneca rejected Pfizer’s initial takeover proposal, but the latest announcement confirms that talks have resumed. Under U.K. takeover regulations Pfizer has until May 26 to make its intentions firm. We all know what that means—attorneys on these deal teams can expect to be working round-the-clock until then. Extra points for Skadden and Freshfields, each involved in &lt;a href=&quot;/blog/vaults-law-blog-legal-careers-and-industry-news/which-lawyers-are-lining-up-for-botox/&quot; target=&quot;_blank&quot;&gt;pharma deals announced last week&lt;/a&gt;. Nice work if you can get it!&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Update:&lt;br /&gt;&lt;/strong&gt;&lt;a href=&quot;http://dealbook.nytimes.com/2014/05/06/astrazeneca-makes-case-against-pfizers-bid/?ref=business&quot; target=&quot;_blank&quot;&gt;AstraZeneca Makes Case Against Pfizer&#39;s Bid&lt;/a&gt;&#160;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Read More:&lt;/strong&gt; &lt;br /&gt; &lt;a href=&quot;/blog/vaults-law-blog-legal-careers-and-industry-news/which-lawyers-are-lining-up-for-botox/&quot; target=&quot;_blank&quot;&gt;Which Lawyers Are Lining Up For Botox?&lt;/a&gt; &lt;br /&gt; &lt;a href=&quot;http://www.americanlawyer.com/id=1202653090791?kw=Pfizer%20Taps%20Skadden%20As%20It%20Guns%20for%20AstraZeneca&amp;amp;et=editorial&amp;amp;bu=The%20American%20Lawyer&amp;amp;cn=20140429&amp;amp;src=EMC-Email&amp;amp;pt=Am%20Law%20Daily&amp;amp;slreturn=20140401094235&quot; target=&quot;_blank&quot;&gt;Pfizer Taps Skadden As It Guns For AstraZeneca&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;em&gt;Follow me on Twitter &lt;a href=&quot;https://twitter.com/VaultLaw&quot; target=&quot;_blank&quot;&gt;@VaultLaw&lt;/a&gt;&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;

Nicole Weber

Article

Which Lawyers Are Lining Up for Botox? 

The Library